Terry Kelly

Terry Kelly is the Chief Innovation Officer at VolitionRx. Prior to joining VolitionRx, Terry was the Global Leader at Agena Bioscience, where Terry led the development of custom assays and services for MassARRAY across multiple locations world-wide. Terry has also worked at Active Motif as the R&D Director, where Terry oversaw the development of assays and services for the life science research reagent market. Terry's experience also includes working as a Postdoctoral Fellow at USC Cancer Center, where Terry studied Epigenetic Mechanisms and Alterations in Cancer. Terry holds a Ph.D. in Neuroscience from UCLA and a B.S. in Biopsychology from UC Santa Barbara.